Glucocorticoids (GC) in SLE on Belimumab 🔹Post-hoc, 5 phase 3 trials 🔹1° endpoint >25% pred↘️ to <7.5mg/d 🔹BEL n=1869; Placebo n=1217 🔹Baseline: 88% on GC; mean ~12.3mg/d pred 🔹Endpoint met by 17% BEL and 12% Pbo (p=0.0024) https://t.co/xp9LamlpHZ #ACR21 Abst#1283 @RheumNow

#ICYMI #ACR21 Watch my interview with ⁦⁦@LatikaGupta_⁩ as she discusses the CoVAD study. @RheumNow ⁦@APLAR_org⁩ ⁦@rheumarhyme⁩ https://t.co/et0X7ltx3K

My Interview with Dr. Seoyoung Kim 👉🏼why/how she got into research 👉🏼her studies on CV risk w/HCQ, real world evidence CV risk w/Tofacitinib, gout T2T MACE occurrence @rheumnow #acr21 https://t.co/RjW5yfyWF6 via @YouTube

Dr. Dellaripa w/great talk on digital ischemia. Presents case of 25 yo F w/SLE, Class IV LN, APS, on apixaban, MMF, HCQ admitted w/AKI, ⬆️Upro & U-blood -> new HFrEF (EF 22%), tachy, & digital ischemia w/skin bx = thrombotic vasculopathy. #ACR21 Scientific Session 9T114 @RheumNow

Had a blast with the @RheumNow team covering #ACR21! Eager to pour over more material over the coming weeks. What did folks do before the abstracts and videos were available online??

Third Time's the Charm - COVID Vaccination While on Rituximab: Dr. Yuz Y... https://t.co/uxA00n1hxy via @YouTube Do watch my short commentary on the enhanced immuno-protection of 3rd primary #COVID dose in patients who are treated with rituximab #ACR21 @RheumNow

Risk of retinopathy vs #lupus flares. Do watch my interview with Dr Jorge on her works on issues surrounding hydroxyxhloroquine dose #ACR21 @RheumNow https://t.co/hKsAi4dD2n

Watch the @RheumNow #rheumatoidarthritis panel discuss some of our highlights from #ACR21! https://t.co/Q5Yps3s165

Do watch the Autoinflammatory Faculty @RheumNow discussed a selection of data presented at #ACR21 @uptoTate @bella_mehta @DrPetryna Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in i... https://t.co/4biuKzWLBc via @YouTube

Impromptu #TeamSparks video meeting with 2nd year fellows @KronzerMD and Dr Gregory McDermott detailing our research findings from the @MassGenBrigham Biobank (funded by @NIH_NIAMS and VERITY) @OrACORe_BWH @MayoClinic @RheumNow #ACR21 https://t.co/CQ9XDamb0E